Candesartan cilexetil 16mg

DRUG3 trials

Sponsors

HK inno.N Corporation, Shin Poong Pharmaceutical Co. Ltd.

Conditions

Essential Hypertension

Phase 2

A Phase 2 Dose Selection Trial of Candesartan Cilexetil and Amlodipine Besylate to Treat Essential Hypertension

HK inno.N CorporationEssential Hypertension

Start: 2014-02-28End: 2015-12-31Target: 384Updated: 2014-04-30

Comparison of Efficacy and Safety of Combination Therapy and Monotherapy of Candesartan and Amlodipine for Dose-Finding in Patients With Essential Hypertension

CompletedNCT02944734

Shin Poong Pharmaceutical Co. Ltd.Essential Hypertension

Start: 2014-09-30End: 2015-12-31Updated: 2016-11-22

Phase 3

A Study to Evaluate the Efficacy and Safety of Amlodipine Besylate and Candesartan Cilexetil in Essential Hypertension Patient Who Are Not Adequately Controlled With Candesartan Cilexetil Monotherapy

CompletedNCT02368652

HK inno.N CorporationEssential Hypertension

Start: 2014-12-31End: 2015-11-30Updated: 2023-05-06

Related Papers

Efficacy and Tolerability of Combination Therapy Versus Monotherapy with Candesartan and/or Amlodipine for Dose Finding in Essential Hypertension: A Phase II Multicenter, Randomized, Double-blind Clinical Trial.

2017-07-1910 citations